InspireMD, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NSPR research report →
About the company
InspireMD, Inc. , an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases.
- CEO
- Marvin L. Slosman
- IPO
- 2011
- Employees
- 85
- HQ
- Miami, IL
Price Chart
- Market Cap
- $32.74M
- P/E
- -1.23
- P/S
- 3.02
- P/B
- 1.18
- EV/EBITDA
- -0.67
- Div Yield
- 0.00%
- Gross Margin
- 28.06%
- Op Margin
- -480.57%
- Net Margin
- -344.13%
- ROE
- -81.52%
- ROIC
- -108.39%
- Revenue
- $8.98M · 28.11%
- Net Income
- $-48,786,000 · -52.43%
- EPS
- $-0.76 · 0.00%
- Op Income
- $-49,112,000
- FCF YoY
- -57.99%
- 52W High
- $2.93
- 52W Low
- $0.63
- 50D MA
- $0.95
- 200D MA
- $1.66
- Beta
- 0.78
- Avg Volume
- 318.53K
Get TickerSpark's AI analysis on NSPR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 27, 26 | Stuka Paul | buy | 20,000 |
| Jan 27, 25 | Gleason Shane Thomas | sell | 3,858 |
| Jan 28, 25 | Gleason Shane Thomas | sell | 2,476 |
| Jan 29, 25 | Gleason Shane Thomas | sell | 3,660 |
| Jan 30, 25 | Gleason Shane Thomas | sell | 2,454 |
| Jan 31, 25 | Gleason Shane Thomas | sell | 9,923 |
| Feb 3, 25 | Gleason Shane Thomas | sell | 7,073 |
| Feb 4, 25 | Gleason Shane Thomas | sell | 5,132 |
| Feb 25, 25 | Gleason Shane Thomas | sell | 10,000 |
| May 23, 25 | Gleason Shane Thomas | sell | 2,482 |
Our NSPR coverage
Recent articles, reports, and earnings notes.
No research on NSPR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NSPR report →Similar companies
Peers in the same neighborhood.